Shanghai Clinical Cohort - Esophageal Cancer
NCT07312526 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2116
Last updated 2026-04-15
Summary
A prospective cohort of patients who received esophagectomy for esophageal cancer in participating centers.
Conditions
- Esophageal Cancer
- Esophagectomy
Interventions
- PROCEDURE
-
esophagectomy
esophagectomy
Sponsors & Collaborators
-
Shanghai Zhongshan Hospital
collaborator OTHER -
Shanghai Cancer Hospital, China
collaborator OTHER -
Changhai hospital of Navy Medical University
collaborator UNKNOWN -
Shanghai Chest Hospital
lead OTHER
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-07-01
- Primary Completion
- 2026-03-31
- Completion
- 2026-03-31
Countries
- China
Study Locations
More Related Trials
-
Phase II Study of Neo-adjuvant Chemoradiotherapy for Squamous Cell Esophageal Cancer
NCT02938195 ·Status: UNKNOWN ·Phase: PHASE2
-
China Early Esophageal Cancer Cohort
NCT06515964 ·Status: RECRUITING
-
Effect of Concurrent Chemoradiation Therapy on Respiratory Muscle Performance, Lung Function and Functional Capacity in Patients With Local Esophagus Cancer
NCT03120572 ·Status: COMPLETED
-
Randomized Controlled Trial to Evaluate Surgical Approaches to Gastric Cancer Invading the Esophagus (JCOG9502)
NCT00149266 ·Status: TERMINATED ·Phase: PHASE3
-
High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer
NCT03535207 ·Status: UNKNOWN ·Phase: NA
-
Two-field Versus Three-field Lymph Node Dissection in ESCC After Neoadjuvant Therapy
NCT05420480 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Surgery or Chemoradiotherapy for Cervical Esophageal Cancer
NCT05327517 ·Status: RECRUITING ·Phase: NA
-
Esophagectomy:Three-field Versus Two-field Lymphadenectomy (ECTOP-2002)
NCT01807936 ·Status: COMPLETED ·Phase: NA
-
Health-related Quality of Life of Patients With Esophageal Cancer After Surgery
NCT01349517 ·Status: UNKNOWN ·Phase: PHASE2
-
Comparison Between NCRT and NCT Followed by MIE for Treatment of Locally Advanced Resectable ESCC
NCT03001596 ·Status: COMPLETED ·Phase: NA
-
Phase II Study of Postoperative Concurrent Chemoradiotherapy for Esophageal Squamous Cell Carcinoma (ESO- Shanghai 17)
NCT04764227 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Improve the Treatment of Thoracic Esophageal Cancer
NCT01137123 ·Status: COMPLETED ·Phase: PHASE3
-
Early Oral Feeding Following Thoracolaparoscopic Oesophagectomy in Patients With Esophageal Cancer
NCT01998230 ·Status: COMPLETED ·Phase: PHASE3
-
Traditional Three Incisions vs Minimally Invasive Thoracol-laparoscopic Esophagectomy for Esophageal Cancer
NCT02355249 ·Status: UNKNOWN ·Phase: PHASE3
-
Postoperative Concurrent Chemoradiotherapy Versus Radiotherapy Alone for Patients With Locoregionally Advanced Esophageal Squamous Cell Carcinoma
NCT03600831 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Neoadjuvant Immunotherapy (PD-1 / PD-L1) Combined With Chemotherapy for Locally Advanced Thoracic Esophageal Squamous Cell Carcinoma: a Single Center, Prospective, Open, One Arm Exploratory Clinical Study
NCT05028231 ·Status: UNKNOWN
-
Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Using CT and Multimodal MRI
NCT06833775 ·Status: NOT_YET_RECRUITING
-
The Phase II Trial of SHR-1210 Combined With Preoperative Chemotherapy or Apatinib for Locally Advanced ESCC
NCT03917966 ·Status: UNKNOWN ·Phase: PHASE2
-
Assessment of Minimally Invasive Surgery for Esophageal Cancer
NCT05662644 ·Status: UNKNOWN ·Phase: NA
-
Neoadjuvant Anti-PD-1 Plus Chemotherapy in Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
NCT05740995 ·Status: RECRUITING
-
Endoscopic Submucosal Dissection Versus Esophagectomy for Early Esophageal Carcinoma
NCT06060106 ·Status: COMPLETED
-
Radiation Dose Escalation in Esophageal Cancer
NCT03082586 ·Status: COMPLETED ·Phase: NA
-
Exploring the Optimal Timing of Minimally Invasive Surgery for Esophageal Squamous Cell Carcinoma
NCT06364566 ·Status: COMPLETED ·Phase: NA
-
Neoadjuvant Chemoradiotherapy Combined With Perioperative Toripalimab in Locally Advanced Esophageal Cancer
NCT04437212 ·Status: UNKNOWN ·Phase: PHASE2
-
A Trial Estimating The Optimal Radiation Volume Of Postsurgical Radiation For Patients With Esophageal Cancer
NCT01391572 ·Status: UNKNOWN ·Phase: PHASE2